Evidence map›Paper›PMID 10768944›Full record

ArticleInfection and immunity2000

Immunization with recombinant Helicobacter pylori urease in specific-pathogen-free rhesus monkeys (Macaca mulatta).

J V Solnick, D R Canfield, L M Hansen, S Z Torabian

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 50 citations in OpenAlex.

  1. Pivotal role ofFrontiers in medicine · 2024
    Review
  2. How Long Will It Take to Launch an EffectiveInfection and drug resistance · 2023
    Review
  3. Article
  4. Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2019
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

J V SolnickDepartment of Internal Medicine (Division of Infectious Diseases), University of California, Davis School of Medicine, Davis, California 95616, USA. jvsolnick@ucdavis.edu
D R Canfield
L M Hansen
S Z Torabian
University of California, Davis · USPrimate Conservation · US

Funding

ZONA PELLUCIDA PEPTIDES AS IMMUNOCONTRACEPTIVE ANTIGENSP51RR000169 · NCRR · UNIVERSITY OF CALIFORNIA DAVIS · PI BARRY, PETER A · 1985 to 2011
$126.2M
Gene expression during H. pylori-host interactionsR01AI042081 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI SOLNICK, JAY V. · 1998 to 2007
$2.5M
NCRR NIH HHS P51 RR000169NCRR NIH HHS RR00169NIAID NIH HHS AI-42081NIAID NIH HHS R01 AI042081
6 · The paper itself

Abstract

Immunization with urease can protect mice from challenge with Helicobacter pylori, though results vary depending on the particular vaccine, challenge strain, and method of evaluation. Unlike mice, rhesus monkeys are naturally colonized with H. pylori and so may provide a better estimate of vaccine efficacy in humans. The purpose of this study was to examine the effectiveness of H. pylori urease as a vaccine in specific-pathogen (H. pylori)-free rhesus monkeys. Monkeys raised from birth and documented to be free of H. pylori were vaccinated with orogastric (n = 4) or intramuscular (n = 5) urease. Two control monkeys were sham vaccinated. All monkeys were challenged with a rhesus monkey-derived strain of H. pylori, and the effects of vaccination were evaluated by use of quantitative cultures of gastric tissue, histology, and measurement of serum immunoglobulin G (IgG) and salivary IgA. Despite a humoral immune response, all monkeys were infected after H. pylori challenge, and there were no differences in the density of colonization. Immunization with urease therefore does not fully protect against challenge with H. pylori. An effective vaccine to prevent H. pylori infection will require different or more likely additional antigens, as well as improvements in the stimulation of the host immune response.

Indexed as

AnimalsAntibodies, BacterialBacterial VaccinesHelicobacter InfectionsHelicobacter pyloriMacaca mulattaRecombinant Fusion ProteinsSpecific Pathogen-Free OrganismsUreaseVaccinationAntibodies, BacterialBacterial VaccinesRecombinant Fusion ProteinsUrease

Identifiers

PMID10768944
PMCPMC97459
OpenAlexW2107105594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.